Acupuncture sets of trial reported core outcomes (ASTRO) for women’s health across the lifespan
Authors:
- Kate M LevettKate M Levett
- Valentina BuayVBValentina Buay
- Claudia CitkovitzCCClaudia Citkovitz
- Kathleen LumiereKLKathleen Lumiere
- Rosa SchnyerRSRosa Schnyer
- Sandro GracaSandro Graca
- Debra BettsDBDebra Betts
- Wen TuWTWen Tu
- Belinda “Beau” AndersonBABelinda “Beau” Anderson
- Lisa ConboyLCLisa Conboy
- Lisa Taylor-SwansonLTLisa Taylor-Swanson
Preprint
Abstract
Introduction: Clinical trials of acupuncture are difficult to meaningfully aggregate due to small sample sizes, and reductionist, heterogenous outcome measures. To improve the quality of evidence, standardized reporting of minimum data that reflects whole-person health, essential to East Asian Medicine (EAM), is needed. The Core Outcome Measures in Effectiveness Trials (COMET) initiative (1) offers a methodology for developing core outcome sets (COS) through collaborative group consensus, including consumers. This study presents the ‘Acupuncture Sets of Trial Reported Outcomes’ (ASTRO) for women’s health. Using domains of pain, sleep, mood/cognition, and safety, the ASTRO framework captures EAM complexity as well as standardizing reporting outcomes. Purpose: To develop a COS for acupuncture trials in women’s health, reflecting whole-person health outcomes across the lifespan. Methods: Following COMET guidelines, we used a three-stage consensus process involving practitioners, researchers, patients, and policymakers to develop a COS for reporting minimum data for acupuncture trials in women’s health. This process involved a systematic review, roundtable discussion, two-round Delphi survey, and a consensus meeting. We examined the conditions of menstrual health, PCOS, fertility, pregnancy, and menopause to develop an outcome set for safety, feasibility and EAM specific outcomes. Results: From 320 studies, 579 outcomes were identified. A final COS of 12 outcomes was agreed upon: Safety (n=2): Serious adverse events (SAEs) and minor adverse events (AEs); EAM (n=8): Changes to primary and secondary patient reported outcome measures (PROMs), change in EAM diagnostic indices, patient experience/satisfaction, demographics, mood/cognition, sleep, and pain; Feasibility (n=2): Acceptability and cost. Definitions for S/AEs follow Witt et al. (2) and Bäumler et al. (3), and outcomes are to be used in conjunction with those specified in the STRICTA guidelines (4). Conclusion: The ASTRO Women’s Health COS enables consistent, whole-person outcome reporting, to improve the quality and comparability of acupuncture research. Summary box: Definitions of terms:Keywords
This publication has 53 references indexed in Scilit:
- Cochrane reviews of acupuncture are dated, do not account for the specific effects of sham controls and likely underestimate the efficacy of acupuncture therapyIntegrative Medicine Research, 2025
- The Cost and Cost-Effectiveness of Childbirth Settings: A Systematic ReviewApplied Health Economics and Health Policy, 2025
- Advanced Acupuncture Research: From Bench to Bedside2022
- Historical perspectives on using sham acupuncture in acupuncture clinical trialsIntegrative Medicine Research, 2021
- Evaluation of outpatient acupuncture for relief of pregnancy‐related conditionsInternational Journal of Gynecology & Obstetrics, 2018
- Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statementFertility and Sterility, 2014
- Acupuncture and acupressure for pain management in labour and birth: A critical narrative review of current systematic review evidenceComplementary Therapies in Medicine, 2014
- The practice of acupuncture and moxibustion to promote cephalic version for women with a breech presentation: Implications for clinical practice and researchComplementary Therapies in Medicine, 2014
- Pain management for women in labour: an overview of systematic reviews2011
- Neuroanatomic Basis of Acupuncture Points2010